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Abstract: Some biocidal agents used for disinfection have been described to enhance antibiotic
resistance in Gram-negative species. The aim of this review was therefore to evaluate the
effect of 13 biocidal agents at sublethal concentrations on antibiotic resistance in Gram-positive
species. A MEDLINE search was performed for each biocidal agent on antibiotic tolerance,
antibiotic resistance, horizontal gene transfer, and efflux pump. Most data were reported with
food-associated bacterial species. In cells adapted to benzalkonium chloride, a new resistance
was most frequently found to ampicillin (seven species), cefotaxime and sulfamethoxazole (six
species each), and ceftazidime (five species), some of them with relevance for healthcare-associated
infections such as Enterococcus faecium and Enterococcus faecalis. With chlorhexidine, a new resistance
was often found to imipenem (ten species) as well as cefotaxime, ceftazidime, and tetracycline
(seven species each). Cross-resistance was also found with triclosan and ceftazidime (eight
species), whereas it was very uncommon for didecyldimethylammonium chloride or hydrogen
peroxide. No cross-resistance to antibiotics has been described after low level exposure to
glutaraldehyde, ethanol, propanol, peracetic acid, octenidine, povidone iodine, sodium hypochlorite,
and polyhexanide. Preference should be given to disinfectant formulations based on biocidal agents
with a low or no selection pressure potential.
Keywords: biocide; cross-resistance; cross-tolerance; antibiotics; antiseptic stewardship
1. Introduction
In some parts of the world, the incidence of nosocomial infections caused by vancomycin-resistant
enterococci (VRE) is increasing [1–3]. The cost of nosocomial VRE infections is substantial [4].
Prior antibiotic treatment has been described to be a relevant risk factor among patients in hematology
and oncology [5]. However, it is currently unknown if other antimicrobial compounds such as specific
biocidal agents used in the immediate patient environment for disinfection may have a similar effect
on the microbial flora on inanimate surfaces or the skin of patients or healthcare workers.
Most users of disinfectants do not expect that some of the biocidal agents in the disinfectants can
cause antibiotic resistance themselves, although it has been shown recently in various Gram-negative
species, especially during low level exposure [6]. There is still a lack of awareness on this topic in
the infection control community [7]. The aim of the review is therefore to summarize data on the
development of antibiotic resistance and tolerance, induction of antibiotic resistance genes, changes
of horizontal gene transfer, and the effect on common efflux pump genes in Gram-positive species
caused by low level exposure to some commonly used biocidal agents. The method is described in
Appendix A.
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2. Benzalkonium Chloride
2.1. Antibiotic Tolerance or Resistance after Low Level Biocide Exposure
One study described an increase of tolerance of Lactobacillus pentosus to some antibiotics such
as chloramphenicol (up to 500-fold), teicoplanin (up to 340-fold), ampicillin (up to 100-fold), or
tetracycline (up to 80-fold) after exposure to a sublethal concentration of benzalkonium chloride
(1 mg/L). The adaptive potential of Leuconostoc pseudomesenteroides was much lower (Table 1).
Table 1. Gram-positive species with increased antibiotic tolerance after various types of low level
exposure (<MIC value) to benzalkonium chloride (BAC).
Species Strain(s) Type of Exposure MIC Increase(BAC) Antibiotic(s)
MIC Increase
(Antibiotic) Reference
Lactobacillus
pentosus
Seven strains from
naturally
fermented
Aloreña green
table olives
48 h at 1 mg/L -
Ampicillin
Chloramphenicol
Ciprofloxacin
Teicoplanin
Tetracycline
Trimethoprim
Clindamycin
Erythromycin
Streptomycin
1-fold–100-fold 1
2-fold–500-fold 1
2-fold–14-fold 1
1-fold–340-fold 1
2-fold–80-fold 1
1-fold–15-fold 1
None 1
None 1
None 1
[8]
Leuconostoc
pseudomesenteroides
Strain from
naturally
fermented
Aloreña green
table olives
48 h at 1 mg/L -
Ciprofloxacin
Chloramphenicol
Tetracycline
Ampicillin
Clindamycin
Erythromycin
Streptomycin
Teicoplanin
Trimethoprim
3-fold 1
2-fold 1
2-fold 1
None 1
None 1
None 1
None 1
None 1
None 1
[8]
1 microdilution method (mg/L); MIC = minimum inhibitory concentration.
Three studies were found describing a new resistance to various antibiotics after exposure to
variable but increasing sublethal concentrations of benzalkonium chloride. In seven species it was a
resistance to ampicillin, in six species a resistance to sulfamethoxazole or cefotaxime, in five species a
resistance to ceftazidime, in three species a resistance to tetracycline, and in one species a resistance
to ciprofloxacin (Table 2). Among the species, some have a major relevance for healthcare-associated
infections, such as Enterococcus faecalis or Enterococcus faecium.
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Table 2. Gram-positive species with a new phenotypic antibiotic resistance after various types of low level exposure (<MIC value) to benzalkonium chloride (BAC).
Species Strain(s) Type of Exposure MIC Increase (BAC) Antibiotic(s) Pre-Value Post-Value Category Reference
Bacillus cereus Five biocide-sensitivestrains from organic foods
Several passages with gradually
higher concentrations
10-fold–
200-fold
Ampicillin
Sulfamethoxazole
Cefotaxime
-
-
-
64 (2) 1
1024 (2) 1
128 (1) 1
R
R
R
[9]
Bacillus licheniformis Two biocide-sensitivestrains from organic foods
Several passages with gradually
higher concentrations
25-fold–
50-fold
Ceftazidime
Cefotaxime
-
-
64 (1) 1
128 (1) 1
R
R [9]
Bacillus spp. Four biocide-sensitivestrains from organic foods
Several passages with gradually
higher concentrations
4-fold–
25-fold
Sulfamethoxazole
Ampicillin
Cefotaxime
-
-
-
1024 (2) 1
64 (1) 1
128 (1) 1
R
R
R
[9]
Enterococcus
casseliflavus
Two biocide-sensitive
strains from organic foods
Several passages with gradually
higher concentrations
10-fold–
20-fold Ampicillin - 32 (1)
1 R [9]
Enterococcus durans Biocide-sensitive strainfrom organic foods
Several passages with gradually
higher concentrations 4-fold Ampicillin - 32
1 R [9]
Enterococcus faecalis Two biocide-sensitivestrains from organic foods
Several passages with gradually
higher concentrations
5-fold–
50-fold
Ceftazidime
Cefotaxime
Sulfamethoxazole
-
-
-
64 (2) 1
128 (1) 1
1024 (1) 1
R
R
R
[9]
Enterococcus faecium Thirteen biocide-sensitivestrains from organic foods
Several passages with gradually
higher concentrations
4-fold–
50-fold
Ampicillin,
Cefotaxime
Ciprofloxacin
Tetracycline
-
-
-
-
16 or 32 (7) 1
64 (3) 1
8 (2) 1
32 (1) 1
R
R
R
R
[9]
Enterococcus spp. Six biocide-sensitive strainsfrom organic foods
Several passages with gradually
higher concentrations
4-fold–
35-fold
Ampicillin
Cefotaxime
Ceftazidime
Sulfamethoxazole
-
-
-
-
16 or 32 (3) 1
64 or 128 (2) 1
64 (2) 1
1024 (1) 1
R
R
R
R
[9]
Listeria monocytogenes 25 strains from food orfood production
Several passages with gradually
higher concentrations
2-fold–
5-fold
Ampicillin
Cefotaxime
Cephalotin
Chloramphenicol
Ciprofloxacin
Erythromycin
Kanamycin
Tetracycline
0.25–2 1
2–16 1
2–32 1
1–8 1
0.5–4 1
0.125–0.5 1
1–4 1
0.5–1 1
0.25–2 1
8–64 1 *
16–64 1 *
1–8 1
1–8 1
0.125–0.5 1
1–4 1
0.5–1 1
-
-
-
-
-
-
-
-
[10]
Listeria monocytogenes Four isolates sensitive toBAC 2–3 w at variable concentrations
4-fold–
6-fold
Gentamicin
Kanamycin
2.25–4.5 1
6.25–12.5 1
1.4–5.5 1
6.25–25 1
-
- [11]
Staphylococcus
saprophyticus
Five biocide-sensitive
strains from organic foods
Several passages with gradually
higher concentrations
10-fold–
200-fold
Sulfamethoxazole
Ceftazidime
Ampicillin
Tetracycline
-
-
-
-
1024 (3) 1
64 (3) 1
64 (2) 1
16 (1) 1
R
R
R
R
[9]
Staphylococcus spp. Four biocide-sensitivestrains from organic foods
Several passages with gradually
higher concentrations
2-fold–
150-fold
Sulfamethoxazole
Ampicillin
Ceftazidime
Tetracycline
-
-
-
-
1024 (3) 1
32 or 64 (3) 1
64 (1) 1
32 (1) 1
R
R
R
R
[9]
1 microdilution method (mg/L); “-” = no information; R = resistant; () = number of strains or isolates; * increase in all strains.
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2.2. Induction of Common Efflux Pumps
Low level exposure of four Listeria monocytogenes isolates susceptible to benzalkonium chloride
was able to increase efflux pump activity in three of them [12]. In a Listeria monocytogenes wild type
outbreak strain, the emrE efflux function was upregulated 49.6-fold [13].
Another interesting observation was made in the Netherlands. The epidemiology of Listeria
monocytogenes meningitis has changed over 25 years. Peak incidence rates were observed in neonates
(0.61 per 100,000 live births) and older adults (peak at 87 years old; 0.53 cases per 100,000 population of
the same age). Whereas most clonal complexes decreased over time, one of them increased significantly
increased (clonal complex 6; from 2% to 26%). The emrC efflux transporter has been shown to be
associated with the emergence of this clonal complex 6 in the Netherlands. The emrC gene encodes an
efflux protein that pumps quaternary ammonium compounds out of the cell. In addition, it increases
the capacity to form a biofilm, both resulting in benzalkonium chloride tolerance. Isolates harboring
emrC were less susceptible to amoxicillin and gentamicin compared with isolates without emrC.
Benzalkonium chloride is extensively used in the foodprocessing industry as a disinfectant agent.
Reduced susceptibility to benzalkonium chloride may be an explanation for the increasing incidence
of clonal complex 6 isolates in the Netherlands between 1985 and 2014 [14].
2.3. Additional Findings
A general adaptation to benzalkonium chloride by Gram-positive bacteria cannot be expected.
When Enterococcus faecalis and Staphylococcus aureus were exposed on agar over 14 passages of 4 days
each to increasing concentrations of benzalkonium chloride, both increases and decreases in antibiotic
susceptibility were found, but its effect was typically small relative to the differences observed among
microbicides. Susceptibility changes resulting in resistance were not observed in this study [15].
In 1632 clinical Staphylococcus aureus isolates, a correlation of susceptibility profiles of at least 0.4 was
found to benzalkonium chloride and the quinolones, beta-lactams, and macrolides [16]. Additionally,
a MIC value > 2 mg/L for benzalkonium chloride was associated with multidrug antibiotic resistance
in Staphylococcus aureus, as demonstrated in 1632 human clinical Staphylococcus aureus isolates from
different geographical regions [17]. Another study with 200 Listeria monocytogenes isolates, however,
showed no association between resistance to benzalkonium chloride and antibiotics [18]. And in five
lactic acid bacteria strains with a resistance to benzalkonium chloride, no cross-resistance to other
antimicrobials was found except for gentamicin [19].
3. Chlorhexidine Digluconate
3.1. Antibiotic Tolerance or Resistance after Low Level Biocide Exposure
One study described that in several Staphylococcus aureus isolates the MIC values for antibiotics
such as tetracycline, amikacin, or gentamicin can increase up to 512-fold after 14 days (Table 3).
Two other studies showed that exposure to variable but increasing sublethal concentrations of
chlorhexidine digluconate can enhance a new resistance to various antibiotics, most frequently to
imipenem (10 species), ceftazidime, tetracycline, or cefotaxime (seven species each), sulfamethoxazole
(five species), and ampicillin (three species). Among the species, some have a major relevance for
healthcare-associated infections, such as Enterococcus faecalis or Enterococcus faecium (Table 4).
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Table 3. Gram-positive species with increased antibiotic tolerance after various types of low level exposure (<MIC value) to chlorhexidine digluconate (CHG).
Species Strain(s) Type of Exposure MIC Increase (CHG) Antibiotic(s) MIC Increase(Antibiotic) Reference
Staphylococcus aureus ATCC 25923 and 14clinical isolates
14 d at various
sublethal
concentrations
4-fold–6-fold (6 isolates)
Ciprofloxacin
Tetracycline
Gentamicin
Amikacin
Cefepime
Meropenem
4-fold–64-fold (6) 1
4-fold–512-fold (15) 1
4-fold–512-fold (8) 1
16-fold–512-fold (11) 1
8-fold–64-fold (11) 1
8-fold–64-fold (9) 1
[20]
1 microdilution method (mg/L); () = number of strains or isolates.
Table 4. Gram-positive species with a new phenotypic antibiotic resistance after various types of low level exposure (<MIC value) to chlorhexidine digluconate (CHG).
Species Strain(s) Type of Exposure MIC Increase(CHG) Antibiotic(s) Pre-Value Post-Value Category Reference
Bacillus cereus Four biocide-sensitivestrains from organic foods
Several passages with
gradually higher
concentrations
6-fold–
16-fold
Imipenem
Sulfamethoxazole
Ampicillin
Tetracycline
-
-
-
-
16 (4) 1
1024 (2) 1
64 (1) 1
32 (1) 1
R
R
R
R
[21]
Bacillus licheniformis Two biocide-sensitivestrains from organic foods
Several passages with
gradually higher
concentrations
4-fold–
10-fold
Imipenem
Cefotaxime
Tetracycline
-
-
-
16 (2) 1
64 (1) 1
32 (1) 1
R
R
R
[21]
Bacillus spp. Four biocide-sensitivestrains from organic foods
Several passages with
gradually higher
concentrations
4-fold–
8-fold
Imipenem
Sulfamethoxazole
Cefotaxime
Ceftazidime
-
-
-
-
16 (4) 1
1024 (4) 1
64 (1) 1
64 (1) 1
R
R
R
R
[21]
Enterococcus casseliflavus Three biocide-sensitivestrains from organic foods
Several passages with
gradually higher
concentrations
8-fold–
20-fold
Imipenem
Cefotaxime
Tetracycline
-
-
-
16 (3) 1
64 (1) 1
32 (1) 1
R
R
R
[21]
Enterococcus durans Biocide-sensitive strainfrom organic foods
Several passages with
gradually higher
concentrations
10-fold ImipenemAmpicillin
-
-
16 1
64 1
R
R [21]
Enterococcus faecalis Biocide-sensitive strainfrom organic foods
Several passages with
gradually higher
concentrations
10-fold ImipenemCeftazidime
-
-
16 1
64 1
R
R [21]
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Table 4. Cont.
Species Strain(s) Type of Exposure MIC Increase(CHG) Antibiotic(s) Pre-Value Post-Value Category Reference
Enterococcus faecium Nine biocide-sensitivestrains from organic foods
Several passages with
gradually higher
concentrations
2-fold–
16-fold
Imipenem
Tetracycline
Ampicillin
Cefotaxime
Ceftazidime
-
-
-
-
-
16 (9) 1
16 or 32 (4) 1
32 or 64 (2) 1
128 (1) 1
64 (1) 1
R
R
R
R
R
[21]
Enterococcus faecium Clinical VRE strain 21 d at variousconcentrations 4-fold Daptomycin 2 3–6
1, 2 - [22]
Enterococcus spp. Six biocide-sensitive strainsfrom organic foods
Several passages with
gradually higher
concentrations
2-fold–
10-fold
Imipenem
Ceftazidime
Sulfamethoxazole
Cefotaxime
Tetracycline
-
-
-
-
-
-
16 (6) 1
64 (5) 1
1024 (5) 1
64–128 (4) 1
16 (3) 1
R
R
R
R
R
[21]
Staphylococcus
saprophyticus
Four biocide-sensitive
strains from organic foods
Several passages with
gradually higher
concentrations
2-fold–
10-fold
Ceftazidime
Imipenem
Sulfamethoxazole
Cefotaxime
Tetracycline
-
-
-
-
-
64 (4) 1
16 (2) 1
1024 (2) 1
128 (2) 1
16 (1) 1
R
R
R
R
R
[21]
Staphylococcus xylosus Biocide-sensitive strainfrom organic foods
Several passages with
gradually higher
concentrations
4-fold
Ceftazidime
Imipenem
Sulfamethoxazole
Cefotaxime
Tetracycline
-
-
-
-
-
64 1
16 1
1024 1
128 1
16 1
R
R
R
R
R
[21]
Staphylococcus spp. Three biocide-sensitivestrains from organic foods
Several passages with
gradually higher
concentrations
4-fold–
10-fold Ceftazidime - 64 (1)
1 R [21]
1 microdilution method (mg/L); 2 subpopulation; “-” = no information; R = resistant; () = number ofstrains or isolates. VRE: vancomycin-resistant enterococci.
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3.2. Effect on Antibiotic Resistance Genes
VanA-type vancomycin resistance gene expression was increased in a vanA Enterococcus faecium
(≥10-fold increase of vanHAX encoding) [23].
3.3. Increase of Horizontal Gene Transfer
In two strains and three derivates of Bacillus subtilis, no increase of transfer of the mobile genetic
element Tn916, a conjugative transposon, was observed [24]. No significant reduction of plasmid
transfer frequency was detected in Staphylococcus aureus [25].
3.4. Additional Findings
When healthcare workers used a soap based on 2% chlorhexidine digluconate, they had a relative
risk of 1.92 and 1.50 of having their hand colonized with a Staphylococcus epidermidis resistant to
oxacillin or resistant to gentamicin, respectively [26]. In Staphylococcus warneri, the relative risk for
rifampicin resistance was even 7.22 [26]. An analysis of 301 Staphylococcus aureus isolates from three
African countries showed a significant association between specific resistance genes for biocidal
agents (sepA, mepA, norA, lmrS, qacAB, smr) and resistance to antibiotics [27]. Recent data show
that exposure of vancomycin-resistant Enterococcus faecium to chlorhexidine digluconate for only
15 min upregulates the vanA-type vancomycin resistance gene (vanHAX) and genes associated with
reduced daptomycin susceptibility (liaXYZ) [28]. In another VRE strain, a subpopulation with reduced
daptomycin susceptibility including significant alterations in membrane phospholipids was detected
after 21 days of chlorhexidine digluconate exposure at various concentrations [22]. In a study, 120
clinical MRSA isolates were exposed to various concentrations of chlorhexidine digluconate (range:
2.5–40 mg/mL), which were allowed to dry in a glass bottle. Possible changes in the susceptibility to
eight antibiotics (ampicillin, tetracycline, vancomycin, gentamicin, oxacillin, cefotaxime, cefuroxime,
ciprofloxacin) were determined. The MICs of cefotaxime, vancomycin, gentamicin, cefuroxime, and
oxacillin increased in the epidemic MRSA strain 16 following 48 h of residue drying. There were also
increases in the MICs of all tested antibiotics for NCTC 6571, a Staphylococcus aureus susceptible strain,
following exposure to chlorhexidine residues that had been drying for 48 h (compared with the MICs
for the strain before exposure). The increases in the MICs of all tested antibiotics for the susceptible
control Staphylococcus aureus strain following exposure to surface dried chlorhexidine residues is of
interest, as it suggests that the use of chlorhexidine in the hospital environment may be linked to
increased resistance to antibiotics in previously susceptible strains [29]. An analysis of 247 nosocomial
Staphylococcus aureus isolates revealed that smr-positive Staphylococcus aureus isolates (44.0%) were
more often resistant to methicillin, ciprofloxacin, and/or clindamycin [30]. The isolates positive for
qacA/B (33.6%) had more often a vancomycin MIC of ≥2 mg/L [30]. An analysis of multiresistance
plasmids found in 280 staphylococcal isolates from diverse geographical regions from the 1940s to
the 2000s suggested that enormous selective pressure has optimized the content of certain plasmids
despite their large size and complex organization [31]. In addition, plasmid pSAJ1 from a methicillin-
and gentamicin-resistant strain of Staphylococcus aureus conferred resistance to chlorhexidine and in
addition to kanamycin, gentamicin, tobramycin, amikacin, benzalkonium chloride, acriflavine, and
ethidium bromide [32]. In 1632 clinical Staphylococcus aureus isolates, a correlation of susceptibility
profiles of at least 0.4 was found to chlorhexidine digluconate and ciprofloxacin [16]. An analysis of
1632 human clinical Staphylococcus aureus isolates from different geographical regions showed that
a MIC value > 2 for chlorhexidine digluconate is associated with multidrug antibiotic resistance in
Staphylococcus aureus [17].
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4. Triclosan
4.1. Antibiotic Tolerance or Resistance after Low Level Biocide Exposure
One study described that in quite a few Lactobacillus pentosus isolates the MIC values for antibiotics
such as teicoplanin, chloramphenicol, or ampicillin can increase up to 340-fold after exposure to 1 mg/L
triclosan over 48 h. Adaptive changes of antibiotic susceptibility was substantially less pronounced in
Leuconostoc pseudomesenteroides (Table 5).
Table 5. Gram-positive species with increased antibiotic tolerance after various types of low level
exposure (<MIC value) to triclosan (TRI).
Species Strain(s) Type ofExposure
MIC
Increase(TRI) Antibiotic(s)
MIC Increase
(Antibiotic) Reference
Lactobacillus
pentosus
Seven strains from
naturally
fermented
Aloreña green
table olives
48 h at
1 mg/L -
Ampicillin
Chloramphenicol
Ciprofloxacin
Teicoplanin
Tetracycline
Trimethoprim
Clindamycin
Erythromycin
Streptomycin
5-fold–100-fold 1
Up to 200-fold (6) 1
Up to 7-fold (6) 1
Up to 340-fold (5) 1
2-fold–80-fold (6) 1
15-fold (1) 1
None
None
None
[8]
Leuconostoc
pseudomesenteroides
Strain from
naturally
fermented
Aloreña green
table olives
48 h at
1 mg/L -
Ciprofloxacin
Chloramphenicol
Tetracycline
Ampicillin
Clindamycin
Erythromycin
Streptomycin
Teicoplanin
Trimethoprim
7-fold 1
2-fold 1
None 1
None 1
None 1
None 1
None 1
None 1
None 1
[8]
1 microdilution method (mg/L); () = number of strains or isolates.
Three other studies showed that exposure to variable but increasing sublethal concentrations of
triclosan can enhance increased tolerance or a new resistance to various antibiotics, most frequently
to ceftazidime (eight species), sulfamethoxazole and cefotaxime (six species each), and ampicillin
(two species). Among the species, at least Enterococcus faecium has relevance for healthcare-associated
infections (Table 6).
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Table 6. Gram-positive species with a new phenotypic antibiotic resistance after various types of low level exposure (<MIC value) to triclosan (TRI).
Species Strain(s) Type of Exposure MIC Increase(TRI) Antibiotic(s) Pre-Value Post-Value Category Reference
Bacillus cereus Five biocide-sensitive strains fromorganic foods
Several passages with gradually
higher concentrations
3-fold–
4-fold
Sulfamethoxazole
Ampicillin
Cefotaxime
Ceftazidime
-
-
-
-
1024 (3) 1
64 (1) 1
128 (1) 1
64 (1) 1
R
R
R
R
[33]
Bacillus licheniformis Biocide-sensitive strain fromorganic foods
Several passages with gradually
higher concentrations 3-fold
Sulfamethoxazole
Ceftazidime
-
-
1024 1
64 1
R
R [33]
Bacillus spp. Four biocide-sensitive strains fromorganic foods
Several passages with gradually
higher concentrations 2-fold
Sulfamethoxazole
Cefotaxime
Ceftazidime
-
-
-
1024 (2) 1
128 (1) 1
64 (1) 1
R
R
R
[33]
Enterococcus
casseliflavus
Biocide-sensitive strain from
organic foods
Several passages with gradually
higher concentrations 2-fold Cefotaxime - 128
1 R [33]
Enterococcus faecium Five biocide-sensitive strains fromorganic foods
Several passages with gradually
higher concentrations
2-fold–
4-fold
Cefotaxime
Ceftazidime
-
-
64 (1) 1
64 (1) 1
R
R [33]
Enterococcus spp. Two biocide-sensitive strains fromorganic foods
Several passages with gradually
higher concentrations 2-fold Ceftazidime - 64 (1)
1 R [33]
Lactobacillus
rhamnosus Strain AC413
10 passages of 4 h at various
concentrations None
Metronidazole
Tetracycline
500 1
5.2 1
500 1
3.9 1
-
- [34]
Listeria monocytogenes Eight strains from different sources 4 × 24 h (1 and 4 mg/L) - Gentamicin 5–20 1 40–160 1 - [35]
Staphylococcus
saprophyticus
Three biocide-sensitive strains
from organic foods
Several passages with gradually
higher concentrations
3-fold–
5-fold
Sulfamethoxazole
Cefotaxime
Ceftazidime
-
-
-
1024 (2) 1
128 (1) 1
64 (1) 1
R
R
R
[33]
Staphylococcus xylosus Biocide-sensitive strain fromorganic foods
Several passages with gradually
higher concentrations 5-fold
Sulfamethoxazole
Ceftazidime
-
-
1024 1
64 1
R
R [33]
Staphylococcus spp. Two biocide-sensitive strains fromorganic foods
Several passages with gradually
higher concentrations
2-fold–
150-fold
Sulfamethoxazole
Ceftazidime
Cefotaxime
Ampicillin
-
-
-
-
1024 (2) 1
32 or 64 (2) 1
128 (1) 1
64 (1) 1
R
R
R
R
[33]
Streptococcus mutans NCTC 10832 10 passages of 4 h at variousconcentrations None
Metronidazole
Tetracycline
62.5 1
1.0 1
62.5 1
2.0 1
-
- [35]
Streptococcus oralis NCTC 11427 10 passages of 4 h at variousconcentrations 1.7-fold
Metronidazole
Tetracycline
62.5 1
7.8 1
125 1
3.9 1
-
- [35]
Streptococcus sanguis NCTC 7863 10 passages of 4 h at variousconcentrations None
Metronidazole
Tetracycline
62.5 1
7.8 1
125 1
7.8 1
-
- [35]
1 microdilution method (mg/L); “-” = no information; R = resistant; () = number of strains or isolates.
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In dust, a significant positive association between the ubiquitous antimicrobial triclosan
and the relative abundance of the antibiotic resistance gene erm(X) was observed; a 23S rRNA
methyltransferase implicated resistance to several antibiotics [36].
4.2. Increase of Horizontal Gene Transfer
In Staphylococcus aureus, an additional sh-fabI allele derived from Staphylococcus haemolyticus was
detected. Detection of sh-fabI as a novel resistance mechanism with high potential for horizontal gene
transfer demonstrates for the first time that a biocide could exert a selective pressure able to drive the
spread of a resistance determinant in a human pathogen [37]. In addition, both the introduction of a
plasmid expressing the saFabI gene or a missense mutation in the chromosomal saFabI gene led to
triclosan resistance in Staphylococcus aureus [38].
4.3. Additional Findings
The triclosan resistance mechanisms are the same types of mechanisms involved in antibiotic
resistance, and some of them account for the observed cross-tolerance with antibiotics in laboratory
isolates. Therefore, there is a link between triclosan and antibiotics, and the widespread use of
triclosan-containing antiseptics and disinfectants may indeed aid in the development of microbial
resistance, in particular cross-resistance to antibiotics [39]. A triclosan-tolerant Staphylococcus aureus
strain did not reveal a cross-resistance to any of the 33 tested antibiotics [40]. In addition, in 1632 clinical
Staphylococcus aureus isolates no cross-resistance was detected to any clinically relevant antibiotic [16].
Finally, an investigation of indoor dust revealed that dust with high triclosan content contained
increased Gram-positive species with diverse drug resistance capabilities, whose pangenomes were
enriched for genes encoding osmotic stress responses, efflux pump regulation, lipid metabolism, and
material transport across cell membranes [41].
5. Didecyldimethylammonium Chloride
One study showed that didecyldimethylammonium chloride (DDAC)-MICs were positively
correlated with several other antibiotic MICs (e.g., chloramphenicol in Enterococcus faecalis),
and increased DDAC-MICs were statistically linked to high-level resistance to streptomycin in
enterococci [42]. In Listeria monocytogenes, resistance to tetracycline and streptomycin was described in
one of 31 strains [43]. Overall, however, exposure of two species (Enterococcus faecalis, Staphylococcus
aureus) over 14 passages of 4 days each to increasing DDAC concentrations on agar was associated
with both increases and decreases in antibiotic susceptibility, but its effect was typically small relative
to the differences observed among microbicides. Susceptibility changes resulting in resistance were
not observed [15].
6. Hydrogen Peroxide
In Staphylococcus aureus NCIMB 9518, an unstable resistance to ciprofloxacin was detected after
exposure to sublethal concentrations of hydrogen peroxide [44]. Another finding was described in
Bacillus subtilis cells. The transfer of the mobile genetic element Tn916, a conjugative transposon and
the prototype of a large family of related elements, was not increased by exposure to 0.002% hydrogen
peroxide for up to 2 h [24].
7. Polyhexanide
Exposure of Enterococcus faecalis and Staphylococcus aureus over 14 passages of 4 days each to
increasing polyhexanide concentrations on agar was associated with both increases and decreases in
antibiotic susceptibility, but its effect was typically small relative to the differences observed among
microbiocides. Susceptibility changes resulting in resistance were not observed [15]. No other data
were found.
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8. Sodium Hypochlorite
In 1632 clinical Staphylococcus aureus isolates, no correlation of susceptibility profiles was found to
sodium hypochlorite and any clinically relevant antibiotic [16].
9. Other Biocidal Agents
No cross-tolerance or cross-resistance to antibiotics has so far been described in Gram-positive
bacterial species for glutaraldehyde, ethanol, propanol, peracetic acid, octenidine, and povidone iodine.
10. Discussion
Biocidal agents used for chemical disinfection in healthcare or food processing are one of many
elements to limit the spread of antibiotic resistant bacteria. Most users of chemical disinfectants
do not expect that these biocidal agents may cause antibiotic resistance themselves. Triclosan is a
prominent example. It was used for decades in antimicrobial soaps in the domestic setting in the US
and considered to be safe and effective [45]. In 2016, however, 19 active ingredients including triclosan
were banned by the US Food and Drug Administration for antimicrobial soaps used at home by the
general population [46]. The decision was justified by associated risks including antibiotic resistance
and a lack of a health benefit (page 61107): “A risk must be balanced by a demonstration—through
studies that demonstrate a direct clinical benefit (i.e., a reduction of infection)—that the product is
superior to washing with non-antibacterial soap and water in reducing infection.” One of the associated
risks is obviously the possibility of bacterial species developing antibiotic resistance.
Some Gram-positive species are able to exhibit a tolerance or even resistance to various antibiotics
after exposure to sublethal concentrations of a few biocidal agents used for disinfection, especially
benzalkonium chloride, chlorhexidine digluconate, and triclosan. Other biocidal agents, however,
did not enhance antibiotic resistance. Based on these finding, it seems only logical to review the
use of biocidal agents for disinfection and to prefer those agents with lower or no potential to
cause antimicrobial tolerance or resistance, as proposed before for Gram-negative species [6]. It is
also advisable to review disinfectant product groups (e.g., alcohol-based hand rubs). They are
typically the first choice for healthcare workers to decontaminate their hands with the aim of reducing
healthcare-associated infections [47]. Additional biocidal agents in alcohol-based hand rubs, such as
chlorhexidine digluconate or octenidine, for example, have no evidence for any health benefit [48].
As a consequence, their use should be reviewed. Preference should be given to products without
additional biocidal agents as long as they have equivalent user acceptability and efficacy for hand
disinfection (“antiseptic stewardship”) [49]. The Commission for Hospital Hygiene and Infection
Control (KRINKO) at the Robert Koch-Institute, Berlin, Germany, has therefore published in its
guideline that alcohol-based hand rubs with persistent biocidal agents cannot be recommended [50].
Antibiotic resistance is a major concern, with an estimated 671,689 infections caused by
antibiotic-resistant bacteria in Europe in 2015, of which 63.5% were associated with healthcare [51].
A major limitation of this review is that most data demonstrating an adaptive change of Gram-positive
species were reported with food-associated species, although the typical nosocomial pathogens
Enterococcus faecium and Enterococcus faecalis were also found. It is therefore difficult to say if these
findings can also be expected with typical healthcare-associated Gram-positive bacterial species.
11. Conclusions
Antibiotic resistance may occur after exposure of various Gram-positive species, mainly
Enterococcus spp., to sublethal concentrations of some biocidal agents such as benzalkonium chloride,
chlorhexidine, or triclosan. With an increase of nosocomial VRE infections, these antiseptic agents
should be used only for applications with a proven health benefit. General preference should be given
to biocidal agents without or with a low selection pressure, assuming that their antimicrobial activity,
material compatibility, and user safety is at least as good for the intended use.
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Appendix A
The following biocidal agents were reviewed: triclosan, benzalkonium chloride,
hydrogen peroxide, glutaraldehyde, ethanol, chlorhexidine digluconate, sodium hypochlorite,
didecyldimethylammonium chloride (DDAC), octenidine, peracetic acid, propanol, polyhexanide,
and povidone iodine. A MEDLINE search was performed on 14 January 2019. For “horizontal
gene transfer”, antibiotic, and each biocidal agent, the MEDLINE search revealed five hits for
hydrogen peroxide, four hits for ethanol and triclosan, two hits for benzalkonium chloride, one hit for
chlorhexidine digluconate, glutaraldehyde, sodium hypochlorite, propanol, povidone iodine, peracetic
acid, and octenidine, and no hits for DDAC and polyhexanide. For “cross tolerance”, antibiotic, and
each biocidal agent, the MEDLINE search revealed eight hits for ethanol, seven hits for benzalkonium
chloride and hydrogen peroxide, four hits for povidone iodine, three hits for sodium hypochlorite
and glutaraldehyde, one hit for propanol, polyhexanide, chlorhexidine digluconate, octenidine, and
peracetic acid, and no hits for DDAC. For “cross resistance”, antibiotic, and each biocidal agent,
the MEDLINE search revealed 46 hits for triclosan, 41 hits for benzalkonium chloride, 37 hits for
hydrogen peroxide, 28 hits for chlorhexidine digluconate, 26 hits for ethanol, 23 hits for povidone
iodine and glutaraldehyde, 12 hits for sodium hypochlorite, eight hits for peracetic acid, three hits
for propanol and octenidine, two hits for polyhexanide, and one hit for DDAC. For “efflux pump”,
antibiotic, and each biocidal agent, the MEDLINE search revealed 41 hits for triclosan, 38 hits for
benzalkonium chloride, 15 hits for hydrogen peroxide, 14 hits for ethanol, eight hits for propanol, six
hits for chlorhexidine digluconate, four hits for glutaraldehyde, two hits for sodium hypochlorite, one
hit for octenidine, peracetic acid, and povidone iodine, and no hits for DDAC and polyhexanide.
Publications were included and results were extracted from them when they provided original
data on an adaptive response to the exposure of Gram-positive bacteria to sublethal concentrations
of the biocidal agents described above resulting in a tolerance or resistance to antibiotics including
antibiotic resistance gene changes, a change of efflux pump activity, or horizontal gene transfer.
Articles were excluded when they described changes in Gram-negative species, fungi, or mycobacteria.
Reviews were also excluded but screened for any information within the scope of the review.
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